21 May 2026
New evidence for coronary revascularisation
Session comprising selected EuroPCR 2026 late-breaking trials submissions
Anchorperson:
H. Krumholz
Spokesperson:
R. Davies
Summary
This session highlights new evidence in coronary revascularisation, including the role of CT-derived virtual stenting for procedural optimization, left ventricular unloading during complex PCI, long-term outcomes of FFR-guided PCI versus medical therapy, Impella CP support in high-risk PCI, and comparative results of PCI versus CABG in diabetic patients with multivessel disease.